NCT03694002 2025-10-30
Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery
SWOG Cancer Research Network
Phase 2 Completed
Clinical Trials
14 trialsNCT01306045 2024-10-01
Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01621568 2024-09-24
Sunitinib for Advanced Thymus Cancer Following Earlier Treatment
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT04925947 2024-04-16
A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors
Weill Medical College of Cornell University
Phase 2 Terminated
NCT00010257 2023-06-29
Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT03193437 2023-02-16
SELECT
Georgetown University
Phase 2 Terminated
NCT02364076 2019-12-13
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
Georgetown University
Phase 2 Unknown
NCT00198133 2019-07-22
Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma
Indiana University
Phase 2 Completed
NCT01364727 2019-04-16
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Stanford University
Phase 2 Completed
NCT01011439 2019-02-06
Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
Tiziana Life Sciences LTD
Phase 2 Terminated
NCT01301391 2019-02-06
Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
Tiziana Life Sciences LTD
Phase 2 Terminated
NCT00965250 2016-12-23
Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00589290 2015-09-30
Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00718809 2015-06-10
Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer
National Cancer Institute (NCI)
Phase 2 Terminated